Prohibiting an insurer, based solely on information about the purchase or possession of an opioid overdose reversal drug by an applicant or insured or a prescription for an opioid overdose reversal drug prescribed to an applicant or insured, from taking certain actions relating to a policy of life insurance; and applying the Act to life insurance policies issued, delivered, or renewed in the State on or after January 1, 2020.
Bill File Type: Regular
Effective Date(s): January 1, 2020
( 27-501 )
Last Updated: 2/3/2020 2:33 PM